Scientists Uncover PPARD Protein's Immune-Boosting Role Against Colorectal and Other Cancers

A Hidden Ally in the Fight Against Cancer

According to НВ — Техно: On October 16th at 10:59 PM, researchers at Cold Spring Harbor Laboratory (CSHL) revealed an unexpected function of the PPARD protein in cancer defense. While PPARD has been known for promoting tumor cell growth, activating it within immune cells significantly enhances their ability to attack tumors. These groundbreaking findings, published in Nature Immunology, could transform treatments for colorectal cancer as well as other malignancies.

Insights from Experimental Studies

PPARD acts as a transcription factor regulating genes that enable cells to burn fat for energy. When activated within immune cells, PPARD boosts their cancer-fighting capabilities. The team conducted a series of experiments using genetically engineered CAR-T cells with activated PPARD in mouse models of colorectal cancer. Additional tests were performed on lab-grown organoids and mice implanted with human cancer cells.

This approach demonstrated effectiveness not only against colorectal cancer but also showed promise in combating:

• breast cancer,
• ovarian cancer,
• melanoma.

Colorectal cancer remains one of the leading causes of death among individuals under 50 years old worldwide. Additionally, about 10% of women globally suffer from endometriosis, highlighting the broader significance of this research to immune-related diseases.

Associate Professor Semir Beyaz, the study’s lead author, compared PPARD’s dual nature to the Force in 'Star Wars': 'In cancer cells, it plays the dark side, but once activated in immune cells, it becomes a powerful tool restoring balance and empowering the light side to overcome disease.'

These discoveries open new avenues for cancer therapy by demonstrating that proteins traditionally seen as cancer promoters can, under specific conditions, enhance immune responses against tumors. The study emphasizes the importance of examining molecular functions within the immune context, potentially leading to more precise and effective cancer treatments in the future.

As researchers continue to explore innovative cancer therapies, another significant advancement comes from Oregon, where scientists have engineered lipid nanoparticles targeting lung cancer and muscle wasting. This development complements the findings on the PPARD protein by showcasing the diverse strategies being employed to enhance immune responses against various cancers and improve patient outcomes.